WuXi AppTec (OTCMKTS:WUXAY) Reaches New 12-Month High – Here’s Why

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAYGet Free Report)’s share price reached a new 52-week high during trading on Friday . The company traded as high as $20.00 and last traded at $19.70, with a volume of 4558 shares. The stock had previously closed at $18.56.

Wall Street Analyst Weigh In

Separately, Zacks Research raised WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Check Out Our Latest Research Report on WUXAY

WuXi AppTec Stock Up 2.1%

The company has a 50 day moving average price of $17.13 and a 200-day moving average price of $15.54.

WuXi AppTec (OTCMKTS:WUXAYGet Free Report) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.05. The business had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.59 billion.

About WuXi AppTec

(Get Free Report)

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.

Further Reading

Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.